In the April edition of the International Pharmaceutical Industry Journal, you can read about the science and our work to improve the outcomes for gastric cancer patients through our innovative daily oral chemotherapy drug candidate, Oncoral (page 30-33)
This article has been published in Volume 14, Issue 1 of International Pharmaceutical Industry.
